Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ERTUGLIFLOZIN PIDOLATE Cause Erythema? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Erythema have been filed in association with ERTUGLIFLOZIN PIDOLATE (STEGLATRO). This represents 0.7% of all adverse event reports for ERTUGLIFLOZIN PIDOLATE.

5
Reports of Erythema with ERTUGLIFLOZIN PIDOLATE
0.7%
of all ERTUGLIFLOZIN PIDOLATE reports
0
Deaths
4
Hospitalizations

How Dangerous Is Erythema From ERTUGLIFLOZIN PIDOLATE?

Of the 5 reports, 4 (80.0%) required hospitalization.

Is Erythema Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ERTUGLIFLOZIN PIDOLATE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ERTUGLIFLOZIN PIDOLATE Cause?

Fungal infection (58) Product dose omission issue (57) Nausea (55) No adverse event (53) Urinary tract infection (52) Diabetic ketoacidosis (34) Dizziness (33) Vomiting (31) Blood glucose increased (30) Product dose omission (27)

What Other Drugs Cause Erythema?

ADAPALENE (38,965) AVOBENZONE\OCTISALATE\OCTOCRYLENE (30,872) DUPILUMAB (10,877) ADALIMUMAB (4,829) ETANERCEPT (3,733) AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE (3,462) INFLIXIMAB (2,919) METHOTREXATE (2,835) SECUKINUMAB (2,824) RITUXIMAB (2,460)

Which ERTUGLIFLOZIN PIDOLATE Alternatives Have Lower Erythema Risk?

ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN ETHYLSUCCINATE ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN LACTOBIONATE ERTUGLIFLOZIN PIDOLATE vs ERYTHROPOIETIN ERTUGLIFLOZIN PIDOLATE vs ESCHERICHIA COLI

Related Pages

ERTUGLIFLOZIN PIDOLATE Full Profile All Erythema Reports All Drugs Causing Erythema ERTUGLIFLOZIN PIDOLATE Demographics